EUROPE HAIR LOSS TREATMENT MARKET 2021-2028

Lifesciences | Healthcare & Wellness

EUROPE HAIR LOSS TREATMENT MARKET 2021-2028

Market by Gender, Indications, Treatment Type, Sales Channel, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The hair loss treatment market in Europe is likely to develop with a CAGR of 4.96% over the forecasting years between 2021 and 2028, states a report by Triton Market Research.


Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in this market include:

•           The United Kingdom

•           Germany

•           Spain

•           France

•           Italy

•           Russia

•           Rest of Europe countries

German consumers are extremely concerned about grooming and appearance, and spend significantly on personal care products, including those for hair care. Baldness is a major concern among Germans. There has been a rise in the cases of hair fall and baldness among people here, with a majority of the men opting for hair transplantation, states the German Medical Group.

Further, organizations such as the Alopecia Areata Germany eV support and advise patients suffering from this condition. They also create public awareness about this disease and promote research on alopecia. All these factors have resulted in an increase in the demand for hair loss treatment in the country. Thus, the high consumer spending, growing balding rate, and enhanced consumer awareness are expected to drive the German hair loss treatment market growth.

People in France heavily indulge in smoking and alcohol consumption, which is a major factor contributing to hair loss. Also, diseases like cancer are highly prevalent in the country, owing to which, there is a large number of people suffering from alopecia. These factors have led French consumers to increasingly opt for hair loss treatments, consequently boosting the market growth. Along with this, the presence of several hair clinics equipped with advanced technologies, is also contributing to the growth of the market.

Cellmid is a consumer health company that aims to leverage advanced technologies to tackle conditions commonly associated with aging. Through its wholly-owned subsidiaries Kinera, Advangen, and Lyramid, the company develops and markets novel therapies and diagnostic tests for hair loss, among several other conditions. évolis® is a clinically validated spray-on product designed by Cellmid to treat genetic hair loss with minimal side effects, in both men and women. The company operates in Europe, and recently indulged in a distribution agreement to further explore the European market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE HAIR LOSS TREATMENT MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE HAIR LOSS TREATMENT INDUSTRY

2.2. KEY INSIGHTS

2.2.1. EFFORTS TO DEVELOP STEM CELL HAIR TRANSPLANTATION METHOD

2.2.2. DEVELOPMENT OF ROBOT HAIR RESTORATION SYSTEM

2.2.3. INTENSIVE RESEARCH ON 3D PRINTING TECHNOLOGY FOR HAIR

2.3. PORTERS FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. ACQUISITIONS

2.6.2. PRODUCT DEVELOPMENTS

2.6.3. CONTRACTS & AGREEMENTS

2.6.4. INVESTMENT & EXPANSIONS

2.7. MARKET DRIVERS

2.7.1. RISE IN CASES OF AUTOIMMUNE DISEASE

2.7.2. HIGH CONSUMPTION OF ALCOHOL AND TOBACCO

2.7.3. UNHEALTHY DIETARY HABITS

2.7.4. STRESS AND CHANGING LIFESTYLES

2.8. MARKET CHALLENGES

2.8.1. RISK OF INFECTION OR SIDE EFFECTS

2.8.2. HIGH COST OF TREATMENT

2.9. MARKET OPPORTUNITIES

2.9.1. R&D IN HAIR CLONING TECHNOLOGY

2.9.2. DEVELOPMENT OF BARICITINIB

3. EUROPE HAIR LOSS TREATMENT MARKET OUTLOOK – BY GENDER

3.1. FEMALE

3.2. MALE

4. EUROPE HAIR LOSS TREATMENT MARKET OUTLOOK – BY INDICATIONS

4.1. ANDROGENIC ALOPECIA

4.2. ALOPECIA AREATA

4.3. ALOPECIA TOTALIS

4.4. OTHER INDICATIONS

5. EUROPE HAIR LOSS TREATMENT MARKET OUTLOOK – BY TREATMENT TYPE

5.1. TOPICAL HAIR LOSS TREATMENT,

5.1.1. MINOXIDIL

5.1.2. SHAMPOOS

5.2. ORAL HAIR LOSS TREATMENT

5.2.1. FINASTERIDE

5.2.2. OTHER ORAL HAIR LOSS TREATMENT

5.3. OTHER TREATMENT TYPES

6. EUROPE HAIR LOSS TREATMENT MARKET OUTLOOK – BY SALES CHANNEL

6.1. DRUG STORES & RETAIL PHARMACIES

6.2. HOSPITAL PHARMACIES

6.3. ONLINE PHARMACIES

7. EUROPE HAIR LOSS TREATMENT MARKET – REGIONAL OUTLOOK

7.1. UNITED KINGDOM

7.2. GERMANY

7.3. FRANCE

7.4. SPAIN

7.5. ITALY

7.6. RUSSIA

7.7. REST OF EUROPE

8. COMPETITIVE LANDSCAPE

8.1. TEVA PHARMACEUTICALS

8.2. MERCK & CO

8.3. CIPLA LIMITED

8.4. JOHNSON & JOHNSON

8.5. SUN PHARMACEUTICAL INDUSTRIES LTD

8.6. CONCERT PHARMACEUTICALS INC

8.7. SHISEIDO COMPANY LIMITED

8.8. TAISHO PHARMACEUTICAL CO LTD

8.9. DR REDDYS LABORATORIES

8.10. THE HIMALAYA DRUG COMPANY

8.11. TRANSITIONS HAIR PVT LTD

8.12. LEXINGTON INTERNATIONAL LLC

8.13. ACLARIS THERAPEUTICS

8.14. CELLMID

8.15. DAIICHI SANKYO

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: EUROPE HAIR LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: LIST OF ACQUISITIONS

TABLE 4: LIST OF PRODUCT DEVELOPMENTS

TABLE 5: LIST OF CONTRACTS & AGREEMENTS

TABLE 6: LIST OF INVESTMENT & EXPANSIONS

TABLE 7: EUROPE HAIR LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE HAIR LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)

TABLE 9: EUROPE HAIR LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)

TABLE 10: EUROPE HAIR LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)

TABLE 11: EUROPE HAIR LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)

TABLE 12: EUROPE HAIR LOSS TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)

TABLE 13: EUROPE HAIR LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: PREVALENCE OF DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES IN 2019

FIGURE 3: EUROPE HAIR LOSS TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)

FIGURE 4: EUROPE HAIR LOSS TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)

FIGURE 5: EUROPE HAIR LOSS TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)

FIGURE 6: EUROPE HAIR LOSS TREATMENT MARKET, BY INDICATIONS, 2020 & 2028 (IN %)

FIGURE 7: EUROPE HAIR LOSS TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE HAIR LOSS TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE HAIR LOSS TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE HAIR LOSS TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: EUROPE HAIR LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2020 & 2028 (IN %)

FIGURE 12: EUROPE HAIR LOSS TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)

FIGURE 13: EUROPE HAIR LOSS TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)

FIGURE 14: EUROPE HAIR LOSS TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE HAIR LOSS TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE HAIR LOSS TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)

FIGURE 17: EUROPE HAIR LOSS TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 18: EUROPE HAIR LOSS TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE HAIR LOSS TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE HAIR LOSS TREATMENT MARKET, BY OTHER TREATMENT TYPES, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE HAIR LOSS TREATMENT MARKET, BY SALES CHANNEL, 2020 & 2028 (IN %)

FIGURE 22: EUROPE HAIR LOSS TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE HAIR LOSS TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE HAIR LOSS TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

FIGURE 25: EUROPE HAIR LOSS TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 26: UNITED KINGDOM HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 27: GERMANY HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: FRANCE HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: SPAIN HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: ITALY HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: RUSSIA HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: REST OF EUROPE HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;